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Cochlear implantation in the presence of chronic
suppurative otitis media
P. R. AXON, D. J. MAWMAN*, T. UPILE, R. T. RAMSDEN
Abstract
Nine patients are presented who underwent cochlear implantation in the presence of chronic suppurative
otitis media. Four had a simple tympanic membrane perforation, four had a pre-existing mastoid cavity
and one had cholesteatoma in the ear chosen for implantation. Patients with a simple perforation had a
staged procedure with myringoplasty followed by cochlear implantation after an interval of three months.
Patients with cholesteatoma or with an unstable mastoid cavity were also staged. A mastoidectomy or
revision mastoidectomy was performed with obliteration of the middle ear and mastoid using a superiorly
pedicled temporalis muscle flap and blind sac closure of the external meatal skin. After a further six
months a second stage procedure was performed to confirm that the middle-ear cleft was healthy and to
insert the implant. Patients presenting with a stable mastoid cavity underwent obliteration of the cavity
and implantation of the electrode as a one-staged procedure. To date there have been no serious
problems such as graft breakdown, recurrence of disease or implant extrusion, and all patients are
performing well.
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Introduction
Cochlear implantation has been shown to be a
reliable method of rehabilitation for certain pro-
foundly deaf or deafened individuals Summerneld
and Marshall (1995). Most patients assessed for
cochlear implantation have middle ears which are
free of pathology, and in these patients cochlear
implantation is usually an uncomplicated single-
staged operation. Chronic suppurative otitis media
(CSOM) may be encountered however, either as the
cause of the profound deafness or as a non-
contributory chance finding. Such patients present
the surgeon with a potential problem. Implantation
of a foreign body into a septic field would seem
foolhardy with rejection a worrying possibility;
furthermore the introduction of infection into the
cochlea through the portal of implantation could
have serious effects on the surviving neural elements
which one hopes to stimulate with the implant. This
paper describes the experience of the Manchester
Royal Infirmary cochlear implant programme in
managing nine patients with a profound hearing loss
and CSOM.
Patients and procedures
Between 1988 and 1996 a total of 157 patients
have received cochlear implants in the Manchester
Royal Infirmary/University of Manchester Pro-
gramme (105 adults and 52 children). Of these,
nine (5.7 per cent) were found to have CSOM either
as the cause of the profound hearing loss or as an
incidental finding. The obvious and usual reason for
choosing to implant an ear with CSOM was the
presence of a bilateral disease, but other indications
were the presence of a relative contraindication on
the contralateral side eg labyrinthectomy for
Meniere's disease (one patient), a congenital hearing
loss (one patient) and the presence of some aidable
residual hearing (one patient). The ages of the
patients at implantation ranged from four to 62 years
of age with a mean of 47.6 years. The duration of
profound deafness ranged from one to 44 years with
a mean of 11.5 years (Table I).
Standard pre-operative assessments included high
definition axial CT scans of the petrous bones to
exclude as far as possible new bone formation in the
cochlea. Pure tone audiometry and speech audio-
metry with, and without, hearing aids was performed
together with assessment of lip-reading skills. Pro-
montory stimulation testing was not routinely
performed. Post-implantation testing included free
field audiometry (FFA) using warble tones at octave
frequencies from 250 Hz to 4000 Hz, Bench Kowal
Bamford (BKB) sentence tests, and consonant
confusion tests (VCV). Environmental sound recog-
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TABLE I
PATIENT DETAILS
Patient Age Duration of deafness CSOM Surgery Implant and insertion
1
2
3
4
5
6
7
8
9
53
50
4
47
62
56
59
47
50
13
6
1
10
2
44
5
6
16
TM perforation
TM perforation
TM perforation
TM perforation
Mastoid cavity
Mastoid cavity
Mastoid cavity
Mastoid cavity
Cholesteatoma
Myringoplasty
Myringoplasty
Myringoplasty
Myringoplasty
Single staged procedure
Single staged procedure
2 staged procedure
2 staged procedure
2 staged procedure
Nucleus 22+5
Medek8
Nucleus 22+10
Nucleus 22+0
Nucleus 22+6
Nucleus 18
Nucleus 22+10
Medel 8
Medel 8
nition (ENV) was scored. The tests were carried out
at one month, nine months and 18 months after
switch on.
Four patients presented with simple perforations
of the tympanic membrane, without cholesteatoma.
In none was the middle-ear disease responsible for
the hearing loss. In three there were bilateral
perforations and in two of these individuals the
perforations accompanied profound hearing loss of
unknown cause. The third was a child who had been
deafened, and suffered perforations during treat-
ment for acute lymphoblastic leukaemia. In the
fourth the contralateral ear had had a labyrinthect-
omy for Meniere's disease and was considered
unsuitable. The perforations were repaired using a
temporalis fascia underlay technique. Three healed
at the primary operation. One required a revision
myringoplasty because of graft failure. All had had
an intact drum for at least three months prior to
implantation. All patients had satisfactory CT
images with no sign of ossification in the lumen of
the cochlea. Implantation was uncomplicated in all
cases with complete insertion of the whole electrode
array.
Five patients had, or had had CSOM with
cholesteatoma. In three, there was a stable, well
epithelialized mastoid cavity, and an air-containing
mesotympanum. Two of these patients were treated
by employing a one-stage technique which entailed
removal of the fibro-epithelial lining of the middle
ear and mastoid, and the skin of the bony external
auditory canal, followed by obliteration of the
mastoid cavity with a pedicled temporalis muscle
flap, which also serves to protect the electrode array,
and a blind sac closure of the meatal skin. The third
of this group had a two stage operation. At the first
stage the fibro-epithelial lining of the mastoid cavity
was carefully elevated forwards up to, and beyond,
the facial ridge and the middle ear opened to allow
access to the round window. The flap of temporalis
muscle was then cut and turned into the mastoid
bowl and middle ear and the fibro-epithelial layer
then laid back over it. No blind sac closure was
performed. At the second stage three months later,
dissection deep to the muscle flap allowed easy
access to the round window and a Nucleus 22
channel device was inserted through a separate
cochleostomy without difficulty. No problem was
enountered with any of these patients. All received
Nucleus 22 channel devices although only a partial
insertion (18 channels) was possible in patient 6
(Table I).
Two patients had active CSOM at the time of
presentation. Patient 8 a 45-year-old man had been
born with a total right-sided hearing loss and lost the
hearing in the left ear in adult life. An attic
cholesteatoma was present, although it was by no
means certain that this was responsible for the loss of
hearing. From consideration of neural plasticity
issues it was felt that despite the CSOM the left
ear was the preferred ear for implantation. A two-
stage procedure was proposed. At the first operation
a radical mastoidectomy was carried with eradication
of a fairly circumscribed cholesteatoma from the
attic and mastoid antrum. The cavity was obliterated
using a pedicled temporalis muscle flap and a blind
sac closure performed. At the second stage proce-
dure, after an interval of six months. A healthy cavity
was found. The muscle flap was dissected off the
promontory and a Nucleus 22 channel device was
inserted through a separate cochleostomy.
Patient 9 had had a bilateral CSOM with
cholesteatoma treated with modified mastoidec-
tomies was totally deaf. A Medel implant had been
inserted into the left side at another centre. No
attempt had been made to provide soft tissue
protection for the electrode array which was in
effect covered by no more than the epithelial lining
of the middle ear and mastoid. Not many months
later the patient presented with the electrode
protruding from the external meatus, surrounded
by pus and granulation tissue. A two-stage proce-
dure was planned. At the first stage the electrode
was removed, and a revision mastoidectomy per-
formed with eradication of residual cholesteatoma,
obliteration the Eustachian tube opening, oblitera-
tion of the mastoid with a temporalis muscle flap,
and a blind sac closure of the external meatus. On
this occasion a silastic sheet was placed between the
muscle flap and the promontory, to facilitate access
at the second stage. The second operation was
performed after a further six months. No problem
was found in identifying the promontory. The first
implant had been inserted through the round
window. The replacement, also a Medel device was
inserted through a separate cochleostomy in front of
the round window. Despite the fact that the scala
had been open for at least six months there was very
little fibrosis in its lumen and, such as there was, was
by-passed by the cochleostomy. The ear healed
uneventfully.
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TABLE II
RESULTS OF PRE-OPERATIVE LIP-READING WITH HEARING AID AND POST-OPERATIVE LIP-READING WITH ELECTRICAL STIMULATION
Patient
1
2
4
5
6
7
8
ALR
50
76
74
32
62
68
36
BKB
PI 9
LR+ES
84
98
90
96
98
96
94
PI 18
LR+ES
88
—
100
—
100
98
ALR
39.9
58.8
14.7
29.4
37.8
42.0
29.4
vcv
PI 9
LR+ES
65.1
—
50.4
—
96.6
79.8
PI 18
LR+ES
60.9
—
75.6
—
84
Results
All patients had an uneventful post-operative
recovery. One myringoplasty patient (4) suffered a
subsequent episode of otitis media in the implanted
ear, and this settled promptly on a short course of
antibiotics, without any adverse effects on the drum
or the performance of the implant.
BKB, VCV and ES scores are available at nine
months or earlier for seven out of the nine patients
and at 18 months for five of the nine. Patient 3 is a
child and has not had the conventional adult
assessments shown below. Patient 9 is not available
for testing for geographical and linguistic reasons.
Nevertheless one of the authors has heard her
converse easily in her own language with little
reliance on lip reading and she is very happy with
the result of her implantation.
BKB results with LR+ES were 80 per cent or
better at nine months with a mean of 93 per cent (84
per cent to 98 per cent). At 18 months, the mean
LR+ES was 96.5 per cent (88 per cent to 100 per
cent). In every case there was an improvement in the
scores between nine and 18 months (Table 2, Figure
1). ES scores at nine months ranged from 0 per cent
to 94 per cent with a mean score of 52 per cent and at
18 months ranged from 72 per cent to 88 per cent
with a mean of 82.7 per cent (Table III).
VCV results with LR+ES at nine months ranged
from 50.4 per cent to 96.6 per cent with a mean of 73
• ALR
• Post implant SLR +ES
D Post implant 18 Lfi+ES
FIG. 1
Analyses of the change in accuracy of identification of words
in sentences (BKB) comparing performance when lip-reading
was supplemented by a hearing aid pre-operatively (ALR)
and by implant post-operatively (LR+ES).
per cent. At 18 months, the mean LR+ES was 73.5
per cent (60.9 per cent to 84 per cent) (Table II,
Figure 2). ES scores at nine months ranged from 31.5
per cent to 81.9 per cent with a mean score of 45.2
per cent and at 18 months ranged from 25.2 per cent
to 67.2 per cent with a mean of 43.4 per cent (Table
III).
The mean ENV results at one month was 49.3 per
cent ranging from 37.5 per cent to 75 per cent. At
nine months, a mean score of 66.9 per cent ranging
from 45 per cent to 85 per cent and at 18 months a
mean score of 58.3 per cent ranging from 42.5 per
cent to 77.5 per cent (Table III, Figure 3).
Discussion
Cochlear implantation has been performed in a
series of nine patients with CSOM and profound
deafness. All of these patients have derived great
benefit from the surgery, and it is quite clear to us
that they represent a group which though more
difficult to manage than the 'usual' cochlear implant
patient, should be seriously considered by the teams
engaged in this exciting field of work. Each
individual should have his or her treatment indivi-
dualized, but even so certain general observations
can be made. If a well-performed operation is to seal
off the middle ear, or obliterate the mastoid, there
seems to be little risk of rejection of the implant. A
simple dry perforation can be easily repaired and
should present no long-term problems. It has been
our practice to perform two-stage surgery in this
situation and to observe a soundly healed drum for
three months before proceeding to implantation. No
particular technical problems need be expected at
implantation. Subsequent acute otitis media has not
led to rejection although it would seem sensible to
treat such infections vigorously.
Management becomes more complicated in the
presence of a previous mastoid cavity, be it healthy
or infected, or if cholesteatoma is present in a
previously un-operated ear. The main issues concern
the questions of staging and of obliteration as well as
the actual techniques. Certainly in an ear with
cholesteatoma present, a two-stage procedure is
recommended, with eradication of disease at the
first operation followed by insertion of the implant
six months later if the ear is disease free. It is also
essential to create a strong protective layer of tissue
with which to cover the implant. Simply to insert an
electrode under the epithelial lining of the mastoid is
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TABLE III
RESULTS AT 1, 9 AND 18 months with electrical stimulation alone
Patient
1
2
4
5
6
7
8
PI9ES
0
72
50
38
68
94
58
BKB
PI 18 ES
0
72
88
88
PI9ES
31.5
—
31.5
—
—
81.9
35.7
vcv
PI 18 ES
25.2
—
37.8
—
—
67.2
PI1 ES
37.5
37.5
45
50
50
75
50
ENV
"-PI9ES
45
—
60
—
—
85
77.5
PI 18 ES
42.5
—
55
—
—
—
77.5
to court disaster and virtually guarantee rejection of
the device as was found in Patient 8. Our technique
has been to swing a pedicled flap of temporalis
muscle into the mastoid and middle ear, and either
to perform blind sac closure of the meatal skin, or to
cover the muscle with the preserved lining of the
mastoid if it is healthy. If the mastoid and middle ear
are disease free and stable, the implant may be
inserted at the same operation. If there is any doubt
about eradication of disease a two-stage procedure
must be performed. Elevation of the fibro-epithelial
lining of the mastoid should be carried out meticu-
lously whether it is to be preserved or discarded, to
ensure that no squamous epithelium is left behind
and for the same reason the matsoid bone and any
remaining air cells should be drilled out. Quite
considerable drilling may be necessary in the region
of the upper edge of the mastoidectomy in order to
provide a smooth surface for the temporalis muscle
flap. As in any revision mastoidectomy extra care is
appropriate when elevating soft tissue off the facial
nerve or its canal. If the operation is to be staged one
should consider whether to insert a silastic sheet
between the muscle flap and the promontory. It is
not necessary in the majority of cases, as no great
difficulty is encountered dissecting the flap off the
promontory at the second-stage procedure. It is
• ALR
• Post-implant 9 months LR+ES
• Post-implant 18 months LR+ES
FIG. 2
Analyses of the change in accuracy of identification of vowel-
consonant-vowel syllables (VCV) comparing performance
when lip-reading was supplemented by a hearing aid (ALR)
pre-operatively and by implant post-operatively (LR+ES).
advisable however if the facial nerve is dehiscent so
as to prevent adhesions between the muscle flap and
the nerve.
One of the worries with obliteration operations is
the fear of entrapment of squamous epithelium out
of sight and this remains a niggling anxiety in these
cases. It is a problem that is compounded by the fact
that MR, which might allow one to monitor
developing cholesteatoma is of no use in cochlear
implant patients, not only because of the presence of
the magnet, but because of the signal void which
occurs round implanted metal. The patients in this
series have had no obvious recurrence and undergo
close clinical monitoring.
There are relatively few reports in the literature of
cochlear implantation in the presence of CSOM.
Schlondorff et al. (1989) describe a technique of
implantation in a mastoid cavity by which a full
thickness post-auricular skin flap was swung into the
mastoid bowl to protect the implant. Clark et al.
(1995) described the implantation of three patients
with CSOM without cholesteatoma. All three had
recurrence of their middle ear disease requiring
further surgery. One patient developed infection
within the otic capsule via the cochleostomy and had
to have his implant removed. They concluded that if
implantation was to be considered in the presence of
EJ Post-implant 1 month ES
• Post-implant 9 months ES
D Post-implant 18 months ES
FIG. 3
Analyses of the change in accuracy of identification of
environmental sounds (ENV) by electrical stimulation (ES)
comparing performance at 1, 9 and 18 months post-implant.
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TABLE III
RESULTS AT 1, 9 AND 18 months with electrical stimulation alone
Patient
1
2
4
5
6
7
8
PI9ES
0
72
50
38
68
94
58
BKB
PI 18 ES
0
72
88
88
PI9ES
31.5
—
31.5
—
—
81.9
35.7
vcv
PI 18 ES
25.2
—
37.8
—
—
67.2
PI1 ES
37.5
37.5
45
50
50
75
50
ENV
"-PI9ES
45
—
60
—
—
85
77.5
PI 18 ES
42.5
—
55
—
—
—
77.5
to court disaster and virtually guarantee rejection of
the device as was found in Patient 8. Our technique
has been to swing a pedicled flap of temporalis
muscle into the mastoid and middle ear, and either
to perform blind sac closure of the meatal skin, or to
cover the muscle with the preserved lining of the
mastoid if it is healthy. If the mastoid and middle ear
are disease free and stable, the implant may be
inserted at the same operation. If there is any doubt
about eradication of disease a two-stage procedure
must be performed. Elevation of the fibro-epithelial
lining of the mastoid should be carried out meticu-
lously whether it is to be preserved or discarded, to
ensure that no squamous epithelium is left behind
and for the same reason the matsoid bone and any
remaining air cells should be drilled out. Quite
considerable drilling may be necessary in the region
of the upper edge of the mastoidectomy in order to
provide a smooth surface for the temporalis muscle
flap. As in any revision mastoidectomy extra care is
appropriate when elevating soft tissue off the facial
nerve or its canal. If the operation is to be staged one
should consider whether to insert a silastic sheet
between the muscle flap and the promontory. It is
not necessary in the majority of cases, as no great
difficulty is encountered dissecting the flap off the
promontory at the second-stage procedure. It is
• ALR
• Post-implant 9 months LR+ES
• Post-implant 18 months LR+ES
FIG. 2
Analyses of the change in accuracy of identification of vowel-
consonant-vowel syllables (VCV) comparing performance
when lip-reading was supplemented by a hearing aid (ALR)
pre-operatively and by implant post-operatively (LR+ES).
advisable however if the facial nerve is dehiscent so
as to prevent adhesions between the muscle flap and
the nerve.
One of the worries with obliteration operations is
the fear of entrapment of squamous epithelium out
of sight and this remains a niggling anxiety in these
cases. It is a problem that is compounded by the fact
that MR, which might allow one to monitor
developing cholesteatoma is of no use in cochlear
implant patients, not only because of the presence of
the magnet, but because of the signal void which
occurs round implanted metal. The patients in this
series have had no obvious recurrence and undergo
close clinical monitoring.
There are relatively few reports in the literature of
cochlear implantation in the presence of CSOM.
Schlondorff et al. (1989) describe a technique of
implantation in a mastoid cavity by which a full
thickness post-auricular skin flap was swung into the
mastoid bowl to protect the implant. Clark et al.
(1995) described the implantation of three patients
with CSOM without cholesteatoma. All three had
recurrence of their middle ear disease requiring
further surgery. One patient developed infection
within the otic capsule via the cochleostomy and had
to have his implant removed. They concluded that if
implantation was to be considered in the presence of
EJ Post-implant 1 month ES
• Post-implant 9 months ES
D Post-implant 18 months ES
FIG. 3
Analyses of the change in accuracy of identification of
environmental sounds (ENV) by electrical stimulation (ES)
comparing performance at 1, 9 and 18 months post-implant.
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CSOM, a radical mastoidectomy with obliteration
should be considered. The possibility of infection
entering the inner ear through the cochleostomy has
been considered by Franz et al. (1987) and Jackler et
al. (1986). Irving and Gray (1994) have adopted this
principle in cases of CSOM without cholesteatoma
with a two-stage procedure three to six months
apart.
Jackler, R. K., O'Donoghue, G. M., Schindler, R. A. (1986)
Cochlear implantation: Strategies to protect the implanted
cochlear from middle ear infection. Annals of Otology,
Rhinology and Laryngology 95: 66-70.
Schlondorff, G., Hermes, H., Week, L. (1989) Cochlear
implants bei patientten mit radikalhohle. Head and Neck,
Otolaryngology 37 (10): 423^25.
Summerfield, A. Q., Marshall, D. H. (1995) Cochlear
Implantation in the UK 1990-1994. Main report, report by
the MRC Institute of Hearing Research HMSO, London,
UK pp 63-89.
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